Kevin T DuPrez

1PUBLICATIONS
6CO-AUTHORS
Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 03, 2026
Relcobatinib, a highly selective ATP-competitive ABL1 tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia.

Pageof 1

Frequent Collaborators

1 joint publications

Stefan D Gross

1 joint publications

Christopher A Eide

1 joint publications

Anna Reister Schultz

1 joint publications

Alex Chao